Cinacalcet: The growth rate is 143%, the patent period expires, and the domestic imitation is up again!
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
Manufacturer Supply 99% High Quality Mots C/Tirze/Cagri/Ghk-Cu/Nad+ Reta CAS 1627580-64-6
$75/UNIT FOB
2026-07-18
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Top 10 drugs that lose patent rights in the U.S. market in 2021
-
Top 10 blockbuster drugs with patents expiring in 2020
-
McKinsey Pays to Close a Purdue Liability Chapter
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
West Asia’s Conflict Is Testing the Hidden Fragility of Pharma Trade
Recommend Reading
-
China’s Approval of Pfizer’s GLP-1 Drug Signals a Sharper Obesity Race
-
Novo Nordisk Faces a Compliance Test
-
South Africa Wants Lenacapavir at Home, Not Just Imported
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
BioNTech’s Founders Turn the Page
-
September Anhydrous Hydrogen Fluoride Market Trend Rises
-
September Sees Mainstream Asphalt Prices Falling in Shandong Region
-
Weak Decline in China's Urea Market in September
-
Weak Demand, Butadiene Market Shows Weak Trend in September
-
Calcium Propionate Uses: Food Preservation & Industrial Applications